Antegrade Approach of Percutaneous Coronary Intervention for Chronic Total OcclusionSource of Funding No funding obtained.
Chronic total occlusion (CTO) is a common challenge accounting for 10% of coronary lesions found on coronary angiography. Patients are frequently referred for bypass surgery because percutaneous coronary intervention is challenging in this subset. Recent advances in the hardware as well as the technical expertise and an algorithm approach have improved the success to more than 90%.
Antegrade approach is the cornerstone for managing CTO and has two distinct strategies: antegrade wire escalation, and antegrade dissection and reentry strategy. Step-wise approach to perform these procedures and the use of adjunct imaging are discussed.
KeywordsAntegrade dissection and reentry - Antegrade approach - Antegrade wire escalation - Chronic total occlusion
13. April 2021 (online)
© 2021. Women in Cardiology and Related Sciences. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 1 Yalonetsky S, Osherov AB, Strauss BH. The pathobiology of CTO. In: Waksman R, Saito S, eds. Chronic Total Occlusions: A Guide to Recanalization. 2nd Ed. Chichester: Wiley Blackwell 2013: 3-8
- 2 Rossello X, Pujadas S, Serra A. et al. Assessment of inducible myocardial ischemia, quality of life, and functional status after successful percutaneous revascularization in patients with chronic total coronary occlusion. Am J Cardiol 2016; 117 (05) 720-726
- 3 Azzalini L, Torregrossa G, Puskas JD. et al. Percutaneous revascularization of chronic total occlusions: rationale, indications, techniques, and the cardiac surgeon’s point of view. Int J Cardiol 2017; 231: 90-96
- 4 Safley DM, Koshy S, Grantham JA. et al. Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions. Catheter Cardiovasc Interv 2011; 78 (03) 337-343
- 5 Cardona M, Martín V, Prat-Gonzalez S. et al. Benefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction: insights from a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2016; 18 (01) 78
- 6 Claessen BE, Dangas GD, Weisz G. et al. Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur Heart J 2012; 33 (06) 768-775
- 7 Raja V, Wiegn P, Obel O. et al. Impact of chronic total occlusions and coronary revascularization on all-cause mortality and the incidence of ventricular arrhythmias in patients with ischemic cardiomyopathy. Am J Cardiol 2015; 116 (09) 1358-1362
- 8 Werner GS. Tools & techniques: the antegrade recanalisation technique for CTO. EuroIntervention 2011; 6 (09) 1137-1139
- 9 Maeremans J, Walsh S, Knaapen P. et al. The hybrid algorithm for treating chronic total occlusions in Europe: the RECHARGE registry. J Am Coll Cardiol 2016; 68 (18) 1958-1970
- 10 Galassi AR, Werner GS, Boukhris M. et al. Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club. EuroIntervention 2019; 15 (02) 198-208
- 11 Bakker EJ, Maeremans J, Zivelonghi C. et al. Fully transradial versus transfemoral approach for percutaneous intervention of coronary chronic total occlusions applying the hybrid algorithm: insights from RECHARGE Registry. Circ Cardiovasc Interv 2017; 10 (09) e00525
- 12 Hong SJ, Mintz GS, Ahn CM. et al. IVUS-XPL Investigators. Effect of intravascular ultrasound-guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL randomized trial. JACC Cardiovasc Interv 2020; 13 (01) 62-71
- 13 Maeremans J, Avran A, Walsh S. et al. RECHARGE Investigators. One-year clinical outcomes of the hybrid CTO revascularization strategy after hospital discharge: a sub-analysis of the multicenter RECHARGE registry. J Invasive Cardiol 2018; 30 (02) 62-70
- 14 Walsh SJ, Cosgrove C, Spratt JC, Hanratty CG. A technical focus on antegrade dissection and re-entry for coronary chronic total occlusions: a practice update for 2019. Korean Circ J 2019; 49 (07) 559-567
- 15 Creaney C, Walsh SJ. Antegrade chronic total occlusion strategies: a technical focus for 2020. Interv Cardiol 2020; doi: 10.15420/icr.2020.05 www.ICRjournal.com
- 16 McQuillan C, Jackson MWP, Brilakis ES, Egred M. Uncrossable and undilatable lesions-a practical approach to optimizing outcomes in PCI. Catheter Cardiovasc Interv 2021; 97 (01) 121-126
- 17 Tajti P, Brilakis ES. Chronic total occlusion percutaneous coronary intervention: evidence and controversies. J Am Heart Assoc 2018; 7 (02) e006732